Entering text into the input field will update the search result below

Risk-Based Monitoring Software Market: Competitive Strategy, Benchmarking And Demand Trend Analysis

Jan. 21, 2021 12:50 AM ETDATATRAK International, Inc. (DTRK), EDC, IBM, IRT, ORCL, SAAS
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • In 2018, Bioclinica (US) launched the SMART technology suite available with Medical Imaging, Electronic Data Capture (EDC), and Interactive Response Technology (IRT) combined.
  • In 2019, Veeva Systems (US), acquired Crossix Solutions (US), a provider of privacy-safe US patient data and best-in-class analytics platform to help maximize media and marketing effectiveness.

This report aims to provide detailed insights into the Risk-Based Monitoring Software Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth Analysis:

The Risk Based Monitoring Software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3%.

Download PDF Brochure:

Risk-based Monitoring Software Market

Key Factors Driving Market Growth:

The key factors driving the growth of this risk based monitoring software market are the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials.

Risk-based Monitoring Software Market (MarketsandMarkets)

Competitive Landscape:

The competitive landscape includes the analysis of the key growth strategies adopted by major players to expand their global presence and increase their shares in the market. The key growth strategies adopted by the top players in the market include product launches and approvals, agreements, expansions, and acquisitions. Product approvals and launches were the most widely adopted growth strategies by market players in the last three years to garner a larger share of the market.

Key Players:

  • Oracle (US),
  • Medidata Solutions (US),
  • Parexel (US),
  • Bioclinica (US),
  • Bio-Optronics (US),
  • IBM Corporation (US),
  • Veeva Systems (US),
  • DSG (US),
  • MasterControl (US),
  • ERT (US),
  • Forte Research Systems (US)

Get more crucial industry insights:


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.